The value of entrant manufacturers: a study of competition and risk for donor-funded procurement of essential medicines (Q1991132): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Created claim: Wikidata QID (P12): Q129679960, #quickstatements; #temporary_batch_1724888006188 |
||
(3 intermediate revisions by 3 users not shown) | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1016/j.ejor.2018.06.027 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2809672591 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q4306267 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Dual Sourcing in Repeated Procurement Competitions / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: The Bargaining Problem / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: On the Value of Mitigation and Contingency Strategies for Managing Supply Chain Disruption Risks / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q129679960 / rank | |||
Normal rank |
Latest revision as of 01:33, 29 August 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The value of entrant manufacturers: a study of competition and risk for donor-funded procurement of essential medicines |
scientific article |
Statements
The value of entrant manufacturers: a study of competition and risk for donor-funded procurement of essential medicines (English)
0 references
30 October 2018
0 references
humanitarian logistics
0 references
dual sourcing
0 references
competition
0 references
supply risks
0 references
global health
0 references